All lobbying filings

CAPITOL HILL CONSULTING GROUP

CAPITOL HILL CONSULTING GROUP filed a Q1 report for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) on April 21, 2025, reporting $60,000 in lobbying income.

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) · National trade organization representing the interests of generic drug manufacturers.

All filings by CAPITOL HILL CONSULTING GROUP · Everything ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 4

BRIAN SUTTER

Previously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
WILLIAM STEVE SOUTHERLAND II Former member of Congress

Previously held: William Steve Southerland, II served as the U.S. Representative for Florida's 2nd congressional district from 2011 to 2015.
EMILY ELIZABETH WILKINSON-HOLLAND New on this filing

Previously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)
CHRISTOPHER DAVIS New on this filing

Previously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act.

Medicare/Medicaid

Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform. Issues related to drug shortages

Trade (domestic/foreign)

Issues related to potential tariffs on generic drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.